[go: up one dir, main page]

HUP0101735A3 - Carbapenem derivatives, pharmaceutical compositions thereof and intermediate compounds - Google Patents

Carbapenem derivatives, pharmaceutical compositions thereof and intermediate compounds

Info

Publication number
HUP0101735A3
HUP0101735A3 HU0101735A HUP0101735A HUP0101735A3 HU P0101735 A3 HUP0101735 A3 HU P0101735A3 HU 0101735 A HU0101735 A HU 0101735A HU P0101735 A HUP0101735 A HU P0101735A HU P0101735 A3 HUP0101735 A3 HU P0101735A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
intermediate compounds
carbapenem derivatives
carbapenem
derivatives
Prior art date
Application number
HU0101735A
Other languages
English (en)
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10122499A external-priority patent/JP2000344772A/ja
Priority claimed from JP10203730A external-priority patent/JP2000344773A/ja
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of HUP0101735A2 publication Critical patent/HUP0101735A2/hu
Publication of HUP0101735A3 publication Critical patent/HUP0101735A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0101735A 1998-05-01 1999-04-28 Carbapenem derivatives, pharmaceutical compositions thereof and intermediate compounds HUP0101735A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10122499A JP2000344772A (ja) 1998-05-01 1998-05-01 カルバペネム誘導体、その用途およびその中間体化合物
JP10203730A JP2000344773A (ja) 1998-07-17 1998-07-17 カルバペネム誘導体、およびその用途並びにその中間体化合物
PCT/JP1999/002301 WO1999057121A1 (en) 1998-05-01 1999-04-28 Carbapenem derivatives, utilization thereof and intermediate compounds of the same

Publications (2)

Publication Number Publication Date
HUP0101735A2 HUP0101735A2 (hu) 2001-12-28
HUP0101735A3 true HUP0101735A3 (en) 2002-02-28

Family

ID=26459604

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101735A HUP0101735A3 (en) 1998-05-01 1999-04-28 Carbapenem derivatives, pharmaceutical compositions thereof and intermediate compounds

Country Status (24)

Country Link
US (1) US6410525B1 (hu)
EP (1) EP1078927B1 (hu)
KR (1) KR100589030B1 (hu)
CN (1) CN1163494C (hu)
AR (1) AR018335A1 (hu)
AT (1) ATE337321T1 (hu)
AU (1) AU760386B2 (hu)
BG (1) BG105004A (hu)
BR (1) BR9910098A (hu)
CA (1) CA2330641A1 (hu)
CO (1) CO5011051A1 (hu)
CZ (1) CZ292623B6 (hu)
DE (1) DE69932927D1 (hu)
HU (1) HUP0101735A3 (hu)
ID (1) ID27081A (hu)
NO (1) NO20005480L (hu)
NZ (1) NZ508493A (hu)
PL (1) PL343728A1 (hu)
RU (1) RU2222540C2 (hu)
SK (1) SK16382000A3 (hu)
TR (1) TR200003199T2 (hu)
TW (1) TW528750B (hu)
WO (1) WO1999057121A1 (hu)
YU (1) YU66700A (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2414311C (en) 2000-07-19 2008-01-08 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
SK15822003A3 (sk) * 2001-05-21 2004-06-08 Kyoto Pharmaceutical Industries, Ltd. Karbapenémový derivát
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1443047A4 (en) * 2001-11-05 2005-04-27 Sumitomo Pharma NEW CARBAPENE COMPOUNDS
CA2519794A1 (en) 2003-04-08 2004-10-21 Sumitomo Pharmaceuticals Co., Ltd. Novel carbapenem compounds
US20070265242A1 (en) * 2004-09-03 2007-11-15 Makoto Sunagawa Novel Carbapenem Compound
JPWO2006103999A1 (ja) * 2005-03-25 2008-09-04 大日本住友製薬株式会社 新規なカルバペネム化合物
RU2008108215A (ru) * 2005-08-31 2009-10-10 Вайет (Us) 9-аминокарбонилзамещенные производные глицилциклинов
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
EP2968274B1 (en) 2013-03-15 2019-10-16 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
JP7437847B2 (ja) * 2018-10-01 2024-02-26 アリクサ ファーマシューティカルズ、インコーポレイテッド レレバクタムの誘導体およびその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
FI81576C (fi) 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
DK175029B1 (da) 1988-04-01 2004-05-03 Sankyo Co 2-(heterocyclylthio)carbapenemderivater, farmaceutiske midler indeholdende dem, fremgangsmåde til fremstilling deraf samt deres anvendelse som antibiotika
US5242914A (en) 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
AU646012B2 (en) * 1990-02-23 1994-02-03 Sankyo Company Limited Carbapenem derivatives having antibiotic activity, their preparation and their use
AU644008B2 (en) 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
JP3048196B2 (ja) * 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
DK0882728T3 (da) 1995-12-21 2003-01-06 Sankyo Co 1-methylcarbapenemderivater

Also Published As

Publication number Publication date
ID27081A (id) 2001-02-22
HUP0101735A2 (hu) 2001-12-28
CN1163494C (zh) 2004-08-25
CZ292623B6 (cs) 2003-11-12
EP1078927A1 (en) 2001-02-28
NO20005480L (no) 2000-12-20
ATE337321T1 (de) 2006-09-15
BG105004A (en) 2001-08-31
NO20005480D0 (no) 2000-10-31
AU760386B2 (en) 2003-05-15
AR018335A1 (es) 2001-11-14
DE69932927D1 (de) 2006-10-05
CZ20003954A3 (cs) 2001-04-11
KR100589030B1 (ko) 2006-06-13
CN1307578A (zh) 2001-08-08
NZ508493A (en) 2002-06-28
CA2330641A1 (en) 1999-11-11
SK16382000A3 (sk) 2001-05-10
CO5011051A1 (es) 2001-02-28
WO1999057121A1 (en) 1999-11-11
TR200003199T2 (tr) 2001-03-21
US6410525B1 (en) 2002-06-25
EP1078927A4 (en) 2003-01-08
BR9910098A (pt) 2000-12-26
YU66700A (sh) 2003-01-31
TW528750B (en) 2003-04-21
KR20010043196A (ko) 2001-05-25
RU2222540C2 (ru) 2004-01-27
AU3627299A (en) 1999-11-23
EP1078927B1 (en) 2006-08-23
PL343728A1 (en) 2001-09-10

Similar Documents

Publication Publication Date Title
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
HU9901606D0 (en) Pharmaceutical compositions
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
HUP0202648A3 (en) Imidazolyl derivatives, pharmaceutical compositions containing them and their use
HUP0102453A3 (en) Adenosine derivatives, their use and pharmaceutical compositions containing the compounds
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
GB9827996D0 (en) Pharmaceutical Compositions
HUP0202520A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
PT1466615E (pt) Composição farmacêutica
IL139480A0 (en) Epothilone derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PL343769A1 (en) Pharmaceutical composition
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0202701A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
HUP0202893A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
GB9818591D0 (en) Pharmaceutical composition
HUP0101735A3 (en) Carbapenem derivatives, pharmaceutical compositions thereof and intermediate compounds
GB9809213D0 (en) Pharmaceutical compositions
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
HUP0103184A3 (en) Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them
HUP0104146A3 (en) Pyrano, piperidino, and thiapyrano compounds, pharmaceutical compositions thereof and their intermediates
AUPP332898A0 (en) Pharmaceutical composition
HRP20000530B1 (en) Pharmaceutical compositions